Diplomat Pharmacy

What Diplomat Pharmacy does

Diplomat Pharmacy is a nationally recognized, publicly traded specialty pharmacy headquartered in Flint, Michigan, founded in 1975 and listed on the NYSE under ticker DPLO. The company specializes in the dispensing and clinical management of high-cost specialty medications used to treat complex, chronic, and rare conditions, serving patients, prescribers, payers, and pharmaceutical manufacturers across the United States. Its service model combines medication fulfillment with clinical support, care coordination, and adherence programs designed for therapies that require special handling, administration oversight, or ongoing safety monitoring.

The business operates through multiple specialty pharmacy and related subsidiaries, including the Diplomat Specialty Infusion Group, which extends the platform into home and alternate-site infusion therapies. Between 2014 and 2017, Diplomat executed at least seven acquisitions spanning specialty pharmacy, infusion, biotech services, and pharmaceutical distribution (including BurmansRx for approximately $82.8 million, TNH Advanced Specialty Pharmacy, Affinity Biotech, National Pharmaceutical Services, LDI, and American Homecare Federation), as well as a related communications and adherence services asset. These moves broadened its therapeutic coverage, distribution capabilities, and patient support infrastructure beyond its historical Flint, Michigan retail/specialty base.

Diplomat generates revenue primarily through prescription dispensing and ancillary clinical and support services billed to patients, payers, pharmacy benefit managers (PBMs), and manufacturers. Distribution channels include national payer and PBM contracts, manufacturer limited-distribution agreements, and direct patient fulfillment supported by a workforce of 501–1,000 employees. The company complemented its organic growth with an $88 million capital raise in March 2015 to fund expansion, and supplemented its dispensing platform with related service lines (infusion, communications/adherence, biotech distribution support) that diversify the revenue mix beyond pure prescription margin.

Name

Diplomat Pharmacy

Website

https://diplomatpharmacy.com

Company type

Private

Founded year

1975

Headcount range

501–1,000 employees

Short description

Diplomat Pharmacy is a publicly traded, US-based specialty pharmacy (NYSE: DPLO) founded in 1975 in Flint, Michigan, dispensing and clinically managing high-cost specialty medications for patients with complex, chronic, and rare conditions across the United States.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

akta.pro secondary industries

Infusion & Home Infusion Pharmacy Services (HLAFALAG), Mail-Order & Home Delivery Pharmacies (HLAFALAD)

Keywords

• Specialty pharmacy services
• Specialty medication dispensing
• Infusion therapy services
• Patient care coordination
• Complex condition therapy management

Headquarters

HQ city

Flint

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Diplomat Pharmacy is a nationally recognized specialty pharmacy that dispenses high-cost specialty medications used to treat complex, chronic conditions such as cancer, multiple sclerosis, autoimmune disorders, and inflammatory diseases. The company pairs dispensing with clinical patient support, adherence services, and financial assistance coordination, and operates an infusion therapy line under the Diplomat Specialty Infusion Group. Services are delivered primarily through mail-order fulfillment complemented by clinical pharmacist consultation and manufacturer/payer contracted channels.

Product overview

Optum Specialty Pharmacy is a comprehensive specialty pharmacy platform offering personalized patient care for complex conditions. The core offering is the Optum Specialty Pharmacy service, which provides medication management, 24/7 clinical support, and overnight delivery. This is supported by digital tools including the Optum Specialty Pharmacy mobile app, Optum Connections virtual visit platform, and Schedule My Fill refill management. The platform also includes financial assistance and one-on-one clinical support programs for patients managing conditions including cancer, multiple sclerosis, inflammatory arthritis, Crohn's disease, ulcerative colitis, and viral hepatitis.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Pharmacy Dispensing and Clinical Support Services Nationally recognized specialty pharmacy dispensing services for high-cost medications used in complex, chronic conditions, paired with clinical pharmacist support, patient adherence and education programs, and financial assistance coordination. Sourced via mail-order fulfillment; contracted primarily with payers, PBMs, and manufacturers.
• Diplomat Specialty Infusion Group Specialty infusion therapy services operated under the Diplomat Specialty Infusion Group, providing provider-/clinic-administered infusion therapies and related clinical support as part of Diplomat's vertically integrated offering.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights5 records

Direct peers

• Walgreens Specialty Pharmacy: Specialty arm of Walgreens Boots Alliance delivering specialty medications, clinical management, and adherence support for chronic complex conditions — competes with Diplomat for both limited-distribution drugs and patient referrals.
• US Bioservices (AmerisourceBergen): Specialty pharmacy brand of AmerisourceBergen/Cencora focused on limited-distribution drugs and oncology/biologics — competes with Diplomat for manufacturer partnerships and patient fulfillment.
• Accredo (Express Scripts / Cigna): One of the largest U.S. specialty pharmacies, owned by Express Scripts (Cigna). Competes head-to-head with Diplomat on dispensing of high-cost specialty and complex therapies, clinical patient support, and limited-distribution drug access.
• Amber Specialty Pharmacy: Independent specialty pharmacy providing complex-condition pharmacy, infusion, and clinical support services across multiple U.S. states — a smaller but directly competing specialty pharmacy with overlapping therapy categories.
• Biologics Inc. (McKesson): Specialty pharmacy and clinical services provider (now under McKesson) dispensing oncology and complex-condition therapies with patient support programs — directly comparable specialty dispensing and clinical management offering.
• CVS Specialty (CVS Health): Specialty pharmacy arm of CVS Health, dispensing complex therapies for oncology, MS, HIV and other conditions with integrated Caremark PBM access — the most direct large-scale competitor to Diplomat's specialty model.
• Optum Specialty Pharmacy (OptumRx / UnitedHealth): Specialty pharmacy service providing personalized care, 24/7 clinical support, overnight delivery, and financial assistance programs for complex conditions — the same business model and patient population Diplomat serves.
• PantheRx (now part of MIMEDX network): PANTHERx Rare, a specialty pharmacy focused on rare-disease and specialty medications with high-touch clinical support — directly comparable specialty dispensing model for limited-distribution and orphan therapies.
• Humana Specialty Pharmacy: Specialty pharmacy operated by Humana's Pharmacy Solutions, focused on Medicare and complex-condition therapies such as oncology, MS, and HIV — directly comparable specialty fulfillment capability.

Broad incumbents

• Magellan Rx Management / Prime Therapeutics Specialty: Specialty pharmacy and managed-care pharmacy benefit operations offering specialty drug management and fulfillment — comparable capability set even though bundled within broader PBM/managed-care services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/diplomatrx
• Facebookfacebook.com/diplomatrx
• LinkedInlinkedin.com/company/diplomat-specialty-pharmacy

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diplomat Pharmacy